Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Cancer cachexia syndrome (CCS) is a multifactorial metabolic syndrome affecting a significant proportion of patients. CCS is characterized by progressive weight loss, alterations of body composition and a systemic inflammatory status, which exerts a major impact on the host’s innate and adaptive imm...

Full description

Bibliographic Details
Main Authors: Konstantinos Rounis, Dimitrios Makrakis, Ioannis Gioulbasanis, Simon Ekman, Luigi De Petris, Dimitris Mavroudis, Sofia Agelaki
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Life
Subjects:
immunotherapy
cancer cachexia
resistance to immunotherapy
PD-1
antitumor immunity
tumor microenvironment
Online Access:https://www.mdpi.com/2075-1729/12/6/880

Internet

https://www.mdpi.com/2075-1729/12/6/880

Similar Items